Who
Jamie Dananberg
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Annexon; Chief Medical Officer, Unity Biotechnology.
In numbers
- Trades disclosed
- 44
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $155K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 May 2018
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $32K5,820 at $5.43 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $32K5,820 at $5.43 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —56,250 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —56,250 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $27K5,290 at $5.10 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $27K5,290 at $5.10 | filing |
| 27 Feb 2025filed 3 Mar 2025 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —228,225 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $16K5,521 at $2.96 | filing |
| 27 Feb 2024filed 3 Mar 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —44,963 at $0.00 | filing |
| 16 Feb 2024filed 21 Feb 2024 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 16 Feb 2024filed 21 Feb 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —39,000 at $0.00 | filing |
| 1 Aug 2023filed 2 Aug 2023 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —275,000 at $0.00 | filing |
| 31 Mar 2023filed 3 Apr 2023 | Unity Biotechnology | SEC FORM 4 Sold | $714420 at $1.70 | filing |
| 14 Mar 2023filed 15 Mar 2023 | Unity Biotechnology | SEC FORM 4 Sold | $4,0201,005 at $4.00 | filing |
| 2 Feb 2023filed 3 Feb 2023 | Unity Biotechnology | SEC FORM 4 Sold | $4,177863 at $4.84 | filing |
| 14 Dec 2022filed 15 Dec 2022 | Unity Biotechnology | SEC FORM 4 Sold | $2,8961,016 at $2.85 | filing |
| 18 Nov 2022filed 21 Nov 2022 | Unity Biotechnologyoption or derivative | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 14 Sep 2022filed 15 Sep 2022 | Unity Biotechnology | SEC FORM 4 Sold | $5,24310,923 at $0.48 | filing |
News
No headline names them, or the companies they trade most, lately.